International Bifurcation Study
IBS
International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions
1 other identifier
observational
5,000
1 country
1
Brief Summary
The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers. The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMarch 11, 2019
March 1, 2019
4 years
February 5, 2018
March 7, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Procedural success
Achievement of technical success and with no in-hospital major adverse cardiac events
1 day
Secondary Outcomes (6)
Major Adverse Cardiac and Cerebrovascular Events
6 months, 1 year, 3 years, 5 years
All cause mortality
6 months, 1 year, 3 years, 5 years
Death from cardiac causes
6 months, 1 year, 3 years, 5 years
Myocardial infarction
6 months, 1 year, 3 years, 5 years
Target vessel revascularization
6 months, 1 year, 3 years, 5 years
- +1 more secondary outcomes
Study Arms (1)
PCI of bifurcation lesions
Patients who have undergone bifurcation coronary artery stenting.
Interventions
Different approaches for treatment of bifurcation coronary artery disease.
Eligibility Criteria
Patients with coronary bifurcation lesion treated during PCI
You may qualify if:
- Age ≥ 18 years
- Any type of bifurcation lesion in major epicardial artery
You may not qualify if:
- Patient refused informed consent to participate in the registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meshalkin National Research Center
Novosibirsk, Novosibirsk Oblast, 630055, Russia
Related Publications (1)
Khelimskii D, Bessonov I, Sapozhnikov S, Badoyan A, Baranov A, Mamurjon M, Manukian S, Utegenov R, Krestyaninov O. Impact of Prolonged Dual Antiplatelet Therapy After Bifurcation Percutaneous Coronary Intervention in Patients with High Ischemic Risk. Am J Cardiovasc Drugs. 2024 Jul;24(4):577-588. doi: 10.1007/s40256-024-00657-1. Epub 2024 Jun 13.
PMID: 38871947DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Dmitrii Khelimskii, MD
Meshalkin National Medical Research Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dmitrii Khelimskii
Study Record Dates
First Submitted
February 5, 2018
First Posted
March 1, 2018
Study Start
January 1, 2018
Primary Completion
December 31, 2021
Study Completion (Estimated)
December 31, 2026
Last Updated
March 11, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share